Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Leukemia, Prolymphocytic, T-Cell × venetoclax × Clear all

Sponsor

Conditions

Leukemia, Myeloid, Acute 28 Leukemia, Lymphocytic, Chronic, B-Cell 17 Myelodysplastic Syndromes 9 Lymphoma, Follicular 8 Lymphoma, Non-Hodgkin 7 Precursor Cell Lymphoblastic Leukemia-Lymphoma 6 Lymphoma, Mantle-Cell 6 Leukemia, Myelomonocytic, Chronic 5 Leukemia 5 Multiple Myeloma 4 Recurrence 3 Neoplasms 3 Lymphoma, Large B-Cell, Diffuse 3 Lymphoma, B-Cell, Marginal Zone 3 Leukemia, Myeloid 3 Hematologic Neoplasms 3 Chromosome 17 deletion 3 Waldenstrom Macroglobulinemia 2 Lymphoma, B-Cell 2 Lymphoma 2 Leukemia, Biphenotypic, Acute 2 Breast Neoplasms 2 Tumor Lysis Syndrome 1 Small Cell Lung Carcinoma 1 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1 Precursor B-Cell Lymphoblastic Leukemia-Lymphoma 1 Neuroblastoma 1 Myeloproliferative Disorders 1 Myeloid Malignancy 1 Myeloid Malignancies 1

Interventions

fludarabine phosphate 5 Whole-Body Irradiation 5 Mycophenolic Acid 5 Peripheral Blood Stem Cell Transplantation 4 Cyclosporins 4 Cyclosporine 4 carmustine, poliferprosan 20 drug combination 2 Sirolimus 2 Melphalan 2 Etoposide 2 Cytarabine 2 Cyclophosphamide 2 Carmustine 2 letermovir 1 Tacrolimus 1 Stem Cell Transplantation 1 Interleukin-15 1 Hematopoietic Stem Cell Transplantation 1 Alemtuzumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡